This was a retrospective study to evaluate outcomes and survival in young patients with oral tongue cancer (OTC). A total of 23 patients were identified: 12 with early-stage disease and 11 with advanced stage disease. In young patients with OTC, factors associated with worse outcomes are similar to known predictors in older patients. Expression of p16 was not statistically associated with improved overall survival.
American Journal of Otolaryngology